Proteolytic enzymes, released early in the course of an inflammatory response, hydrolyze fibronectin, producing fragments of the parent molecule that alter monocyte phenotype and migratory behavior. Here we test the hypothesis that macrophages, stimulated by the dominant 110–120 kd fibronectin fragments (FNf), as are found in lymphatic fluid draining sites of cardiac ischemia-reperfusion injury, produce factors that promote the survival of injured parenchymal cells. Rat splenic macrophages stimulated in vitro with purified FNf produced soluble factors that protected hypoxic rat cardiac myocytes from death by apoptosis. Addition of blocking antibodies specific for tumor necrosis factor-α (TNF-α), fibroblast growth factor-1 (FGF-1), insulin-like growth factor I (IGF-I), and leukemia inhibitory factor (LIF) partly reduced the protection against apoptosis provided to hypoxic cardiac myocytes by cell-free culture supernatants from FNf-stimulated macrophages. Complete blockade of this protection was achieved by a combination of antibodies specific for FGF-1, IGF-I, and LIF. Stimulation of human monocyte-derived macrophages in vitro with FNf significantly increased their output of TNF-α, FGF-1, IGF-I, and LIF. These results suggest that tissue degradation products, released in the early hours of an inflammatory response, stimulate tissue-infiltrating macrophages to protect injured but still viable parenchymal cells from death by apoptosis.
RossenRD, MannDL. Myocardial inflammation. In: RichRR, Ed. Clinical Immunology: Principles and practice (2nd ed.). New York: Mosby, pp 80.1–80.15, 2001.
2.
LindseyM, WedinK, BrownMD, KellerC, EvansAJ, SmolenJ, BurnsAR, RossenRD, MichaelLH, EntmanML. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation103: 2181–2187, 2001.
3.
BirdsallHH, GreenDM, TrialJ, YoukerKA, BurnsAR, McKayCR, LaRosaGJ, HawkinsHK, SmithCW, MichaelLH, EntmanML, RossenRD. Complement C5a, TGF-1, and MCP-1, in sequence, induce migration of monocytes into ischemic myocardium within the first 1 to 5 hours following reperfusion. Circulation95: 684–692, 1997.
EntmanML, SmithCW. Postperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res28: 1301–1311, 1994.
6.
WeihrauchD, ArrasM, ZimmermanR, SchaperJ. Importance of monocytes/macrophages and fibroblasts for healing of micronecroses in porcine myocardium. Mol Cell Biochem147: 13–19, 1995.
7.
BoyleMP, WeismanHF. Limitation of infarct expansion and ventricular remodeling by late reperfusion. Circulation88: 2872–2883, 1993.
8.
ClarkRA, WiknerNE, DohertyDE, NorrisDA. Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment. J Biol Chem263: 12115–12123, 1988.
9.
BeezholdDH, PersoniusC. Fibronectin fragments stimulate tumor necrosis factor secretion by human monocytes. J Leukoc Biol51: 59–64, 1992.
10.
TremblePM, DamskyCH, WerbZ. Fibronectin fragments, but not intact fibronectin, signalling through the fibronectin receptor induce metalloproteinase gene expression in fibroblasts. Matrix1(Suppl):212–214, 1992.
11.
ForsythCB, PulaiJ, LoeserRF. Fibronectin fragments and blocking antibodies to alpha2betal and alpha5betal integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum46: 2368–2376, 2002.
12.
FordDA, RovettoMJ. Rat cardiac myocyte adenosine transport and metabolism. Am J Physiol252: H54–H63, 1987.
13.
SunL, ChangJ, KirchhoffSR, KnowltonAA. Activation of HSF and selective increase in heat-shock proteins by acute dexamethasone treatment. Am J Physiol Heart Circ Physiol278: H1091–H1097, 2000.
14.
KirchhoffSR, GuptaS, KnowltonAA. Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation105: 2899–2904, 2002.
15.
NakanoM, MannDL, KnowltonAA. Blocking the endogenous increase in HSP 72 increases susceptibility to hypoxia and reoxygenation in isolated adult feline cardiocytes. Circulation95: 1523–1531, 1997.
16.
KurrelmeyerKM, MichaelLH, BaumgartenG, TaffetGE, PeschonJJ, SivasubramanianN, EntmanML, MannDL. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A97: 5456–5461, 2000.
17.
BuerkeM, MuroharaT, SkurkC, NussC, TomaselliK, LeferAM. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A92: 8031–8035, 1995.
18.
CuevasP, ReimersD, CarcellerF, Martinez-CosoV, Redondo-HorcajoM, Saenz de TejadaI, Gimenez-GallegoG. Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury. Eur J Med Res2: 465–468, 1997.
19.
EddyLI, GoeddelDV, WongGHW. Tumor necrosis factor—a pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun184: 1056–1059, 1992.
20.
NegoroS, KunisadaK, FunamotoM, DarvilleMI, EizirikDL, OsugiT, IzumiM, OshimaY, NakaokaY, HirotaH, KishimotoT, Yamauchi-TakaharaK. Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation104: 979–981, 2001.
21.
WangF, SetaY, BaumgartenG, EngelDJ, SivasubramanianN, MannDL. Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart. Circulation103: 1296–1302, 2001.
22.
ArrasM, StrasserR, MohriM, DollR, EckertP, SchaperW, SchaperJ. Tumor necrosis factor-alpha is expressed by monocyte/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol93: 97–107, 1998.
23.
KlugeA, ZimmermannR, MunkelB, MohriM, SackS, SchaperJ, SchaperW. Insulin-like growth factor I is involved in inflammation linked angiogenic processes after microembolization in porcine heart. Cardiovasc Res29: 407–415, 1995.
24.
KuwabaraK, OgawaS, MatsumotoM, KogaS, ClaussM, PinskyDJ, LynP, LeavyJ, WitteL, Joseph-SilversteinJ, FurieMB, TorciaG, CozzolinoF, KamadaT, SternDM. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci U S A92: 4606–4610, 1995.
25.
ZouY, TakanoH, MizukamiM, AkazawaH, QinY, TokoH, SakamotoM, MinaminoT, NagaiT, KomuroI. Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction. Circulation108: 748–753, 2003.
26.
RenierG, ClementI, DesfaitsA-C, LambertA. Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-a production. Endocrinology137: 4611–4618, 1996.
27.
HamiltonJA, WaringPM, FilonziEL. Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-aJ Immunol150:1496–1502, 1993.
28.
WuW, LeeW, WuY, ChenD, LiuT, SharmaPM, WangPH. Expression of constitutively active phosphatidylinositol 3 kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells. J Biol Chem275: 40113–40119, 2000.
29.
CondorelliG, MoriscoC, LatronicoMVG, ClaudioPP, DentP, TsichlisP, CondorelliG, FratiG, DruscoA, CroceCM, NapoliC. TNF-a signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-a receptor. FASEB J16: 1732–1737, 2002.
30.
ParrizasM, SaltielAR, LeRoithD. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways. J Biol Chem272: 154–161, 1997.
31.
MehrhofFB, MullerFU, BergmannMW, LiP, WangY, SchmitzW, DietzR, von HarsdorfR. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Circulation104: 2088–2094, 2001.
32.
CraigR, LarkinA, MingoAM, ThueraufDJ, AndrewsC, McDonoughPM, GlembotskiCC. p38 MAPK and NF-κB collaborate to induce inter5leukin-6 gene expression and release. J Biol Chem275: 23814–23824, 2000.
